Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03476369 · ClinicalTrials.gov registry record · Phase 4
Fentanyl and Crushed Ticagrelor in Percutaneous Coronary Intervention
A Phase 4 study, sponsored by The Guthrie Clinic.
- Terminated
- Registry status
- Phase 4
- Development phase
- 45
- Enrollment target
NCT03476369 is a Phase 4 study that was terminated before completion, run by The Guthrie Clinic. The registered enrollment target is 45 participants.
The verdict
NCT03476369, a Phase 4 study, was terminated before completion, sponsored by The Guthrie Clinic.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 45 participants
- Enrollment target
Study Summary
During a percutaneous coronary intervention (PCI), Fentanyl is commonly used for sedation. Ticagrelor is also routinely used as anti-platelet agent during PCI. However, a recent study has demonstrated the decrease in effectiveness of Ticagrelor when administered along with Fentanyl. Hence this study was designed to further assess the interaction between crushed vs non crushed Ticagrelor and Fentanyl given during PCI procedures.
Interventions
- DRUG Fentanyl
- DRUG Ticagrelor 90Mg Tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2018-04-18 |
| Est. Completion | 2025-01-23 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03476369
The ClinicalTrials.gov registry entry for NCT03476369 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Guthrie Clinic, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fentanyl is the first listed.
NCT03476369 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03476369 about?
NCT03476369 is a clinical study titled "Fentanyl and Crushed Ticagrelor in Percutaneous Coronary Intervention". During a percutaneous coronary intervention (PCI), Fentanyl is commonly used for sedation. Ticagrelor is also routinely used as anti-platelet agent during PCI. However, a recent study has demonstrated the decrease in effectiveness of Ticagrelor when administered along with Fentanyl. Hence this study...
What is the current status of trial NCT03476369?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 45 participants. The study started on 2018-04-18. Estimated completion is 2025-01-23.
What interventions are being tested in trial NCT03476369?
The interventions under investigation include: Fentanyl (DRUG), Ticagrelor 90Mg Tablet (DRUG).
Who is sponsoring clinical trial NCT03476369?
This trial is sponsored by The Guthrie Clinic, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.